Bispecific monoclonal antibodies, thrombolytic agent and method of cell lysis
AssigneesTakeda Chemical Industries, Ltd., Tokyo Metropolitan Institute of Medical Science
InventorsHiroh Yamazaki, Kenjiro Tanoue, Susumu Iwasa, Tomofumi Kurokawa
Life of this patent
Estimating the term…
Abstract
Disclosed are a bispecific hybrid MoAb having specificity for both an activated platelet and a substance having thrombolytic activity, and a thrombolytic agent comprising the above bispecific MoAb and a substance having thrombolytic activity immunologically bound thereto, whereby efficient, rapid thrombolysis is possible.
Claims13
A bispecific hybrid monoclonal antibody having specificity for both an activated platelet and a protease.
A bispecific monoclonal antibody produced by the mouse hybrid-hybridoma deposited as FERM BP-2845.
A bispecific monoclonal antibody produced by the mouse hybrid-hybridoma deposited as FERM BP-3018.
Dependencies are inferred from the claim text.